• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles.

作者信息

Khoza Leon J, Kumar Pradeep, Dube Admire, Demana Patrick H, Choonara Yahya E

机构信息

Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Parktown 2193, South Africa.

School of Pharmacy, Faculty of Natural Sciences, University of the Western Cape, Cape Town, South Africa.

出版信息

Int J Pharm. 2022 Jun 25;622:121893. doi: 10.1016/j.ijpharm.2022.121893. Epub 2022 Jun 6.

DOI:10.1016/j.ijpharm.2022.121893
PMID:35680110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9169426/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/511c555a9b93/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/2b92578f88e9/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/579c11f245bf/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/d0536f7709b3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/1e54b8fc9e1f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/5f9e6307d8a0/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/35095c5d9f09/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/c2252dcbb1dc/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/511c555a9b93/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/2b92578f88e9/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/579c11f245bf/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/d0536f7709b3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/1e54b8fc9e1f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/5f9e6307d8a0/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/35095c5d9f09/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/c2252dcbb1dc/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd28/9169426/511c555a9b93/gr7_lrg.jpg

相似文献

1
Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles.耐多药结核病创新疗法的见解：宿主导向疗法与自噬诱导修饰纳米颗粒
Int J Pharm. 2022 Jun 25;622:121893. doi: 10.1016/j.ijpharm.2022.121893. Epub 2022 Jun 6.
2
The Macrophage Response to and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy.巨噬细胞对用于结核病治疗的自噬诱导纳米药物的反应及机遇
Front Cell Infect Microbiol. 2021 Feb 8;10:618414. doi: 10.3389/fcimb.2020.618414. eCollection 2020.
3
Autophagy: A new strategy for host-directed therapy of tuberculosis.自噬：一种针对结核病的宿主导向治疗的新策略。
Virulence. 2019 Dec;10(1):448-459. doi: 10.1080/21505594.2018.1536598. Epub 2018 Nov 2.
4
Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of .通过 CLEC4E 与 TLR4 的联合诱导自噬：限制 存活的创新策略。
Autophagy. 2020 Jun;16(6):1021-1043. doi: 10.1080/15548627.2019.1658436. Epub 2019 Sep 8.
5
Mycobacterium tuberculosis PPE51 Inhibits Autophagy by Suppressing Toll-Like Receptor 2-Dependent Signaling.结核分枝杆菌 PPE51 通过抑制 Toll 样受体 2 依赖性信号通路来抑制自噬。
mBio. 2022 Jun 28;13(3):e0297421. doi: 10.1128/mbio.02974-21. Epub 2022 Apr 25.
6
Infection and Innate Responses in a New Model of Lung Alveolar Macrophages.肺泡巨噬细胞新型模型中的感染与固有免疫反应。
Front Immunol. 2018 Mar 12;9:438. doi: 10.3389/fimmu.2018.00438. eCollection 2018.
7
Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy.巴泽多昔芬通过增强自噬来抑制细胞内结核分枝杆菌的生长。
mSphere. 2020 Apr 8;5(2):e00124-20. doi: 10.1128/mSphere.00124-20.
8
Transcription Repressor Protein ZBTB25 Associates with HDAC1-Sin3a Complex in Mycobacterium tuberculosis-Infected Macrophages, and Its Inhibition Clears Pathogen by Autophagy.转录抑制蛋白 ZBTB25 与感染结核分枝杆菌的巨噬细胞中的 HDAC1-Sin3a 复合物相关，其抑制作用通过自噬清除病原体。
mSphere. 2021 Feb 24;6(1):e00036-21. doi: 10.1128/mSphere.00036-21.
9
Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 Proteins Inhibit Autophagy by Interaction with Rab1A.结核分枝杆菌 PE_PGRS20 和 PE_PGRS47 蛋白通过与 Rab1A 相互作用抑制自噬。
mSphere. 2021 Aug 25;6(4):e0054921. doi: 10.1128/mSphere.00549-21. Epub 2021 Aug 4.
10
New insights into the evasion of host innate immunity by Mycobacterium tuberculosis.结核分枝杆菌逃避宿主固有免疫的新见解。
Cell Mol Immunol. 2020 Sep;17(9):901-913. doi: 10.1038/s41423-020-0502-z. Epub 2020 Jul 29.

引用本文的文献

1
Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases.用于治疗和预防肺部感染性疾病的可吸入纳米药物的制剂与临床转化
Drug Deliv Transl Res. 2025 Apr 29. doi: 10.1007/s13346-025-01861-5.
2
Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment.对抗耐多药结核病的创新策略：药物递送系统与治疗的进展
Microorganisms. 2025 Mar 24;13(4):722. doi: 10.3390/microorganisms13040722.
3
Nanosized Drug Delivery Systems to Fight Tuberculosis.

本文引用的文献

1
Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: lung deposition and efficacy studies.负载N-乙酰半胱氨酸的聚乳酸-羟基乙酸共聚物纳米颗粒用于结核病治疗的吸入潜力：肺部沉积和疗效研究
Curr Res Pharmacol Drug Discov. 2022 Jan 18;3:100084. doi: 10.1016/j.crphar.2022.100084. eCollection 2022.
2
Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery.新冠疫情对结核病防治的毁灭性影响——恢复之路
N Engl J Med. 2022 Apr 21;386(16):1490-1493. doi: 10.1056/NEJMp2118145. Epub 2022 Jan 5.
3
Phosphatidylserine Liposomes Reduce Inflammatory Response, Mycobacterial Viability, and HIV Replication in Coinfected Human Macrophages.
用于对抗结核病的纳米级药物递送系统
Pharmaceutics. 2023 Jan 24;15(2):393. doi: 10.3390/pharmaceutics15020393.
磷脂酰丝氨酸脂质体可减少感染人类巨噬细胞中的炎症反应、分枝杆菌活力和 HIV 复制。
J Infect Dis. 2022 May 4;225(9):1675-1679. doi: 10.1093/infdis/jiab602.
4
Physicochemical and Biological Evaluation of Curdlan-Poly(Lactic-Co-Glycolic Acid) Nanoparticles as a Host-Directed Therapy Against Mycobacterium Tuberculosis.壳聚糖-聚（乳酸-共-乙醇酸）纳米粒的理化性质和生物学评价作为一种针对分枝杆菌的宿主导向治疗。
J Pharm Sci. 2022 Feb;111(2):469-478. doi: 10.1016/j.xphs.2021.09.012. Epub 2021 Sep 14.
5
Manipulation of autophagy for host-directed tuberculosis therapy.通过调控自噬进行宿主导向性结核病治疗。
Afr J Thorac Crit Care Med. 2019 Jul 31;25(2). doi: 10.7196/AJTCCM.2019.v25i2.014. eCollection 2019.
6
Autophagy Induction as a Host-Directed Therapeutic Strategy against Infection.自噬诱导作为一种针对 感染的宿主定向治疗策略。
Medicina (Kaunas). 2021 May 23;57(6):522. doi: 10.3390/medicina57060522.
7
Promotion of Anti-Tuberculosis Macrophage Activity by L-Arginine in the Absence of Nitric Oxide.精氨酸在没有一氧化氮的情况下促进抗结核巨噬细胞的活性。
Front Immunol. 2021 May 14;12:653571. doi: 10.3389/fimmu.2021.653571. eCollection 2021.
8
Lipid Nanoparticles as Carriers for Bioactive Delivery.脂质纳米颗粒作为生物活性物质递送载体
Front Chem. 2021 Apr 23;9:580118. doi: 10.3389/fchem.2021.580118. eCollection 2021.
9
Metabolic Regulation of Immune Responses to : A Spotlight on L-Arginine and L-Tryptophan Metabolism.代谢调节免疫应答：聚焦精氨酸和色氨酸代谢。
Front Immunol. 2021 Feb 9;11:628432. doi: 10.3389/fimmu.2020.628432. eCollection 2020.
10
The Macrophage Response to and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy.巨噬细胞对用于结核病治疗的自噬诱导纳米药物的反应及机遇
Front Cell Infect Microbiol. 2021 Feb 8;10:618414. doi: 10.3389/fcimb.2020.618414. eCollection 2020.